Home Compliance Pharmaceutical Suppliers Beware: Expect Increased Scrutiny of Average Wholesale Pricing Methodology and... ComplianceExpert OpinionNews Pharmaceutical Suppliers Beware: Expect Increased Scrutiny of Average Wholesale Pricing Methodology and Marketing “The Spread” May 1, 2023 25 Share FacebookLinkedinTwitter Fahroni | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Is Complaining to Your Supervisor FCA Protected Activity? Court Says Maybe. Compliance Eleventh Circuit Backs Whistleblowers in Important Case Involving the 8(a) Small Business Contracting Program Compliance SEC Whistleblowers Awarded $24 Million